Waystar Holding Corp. (NASDAQ:WAY) is one of the 14 oversold value stocks to invest in right now.
As of February 5, 2026, analyst sentiment on Waystar Holding Corp. (NASDAQ:WAY) remains bullish, with nearly all analysts covering the stock maintaining that view. The consensus price target of $46.00 implies 91.70% upside.
The recent analyst update came on February 2, 2026, from Leerink, which initiated coverage on Waystar Holding Corp. (NASDAQ:WAY) with an ‘Outperform’ rating and $43 price target. The firm’s bullish stance reflects the company’s broad market reach, which acts as a driver for growth and cross-selling opportunities. While pointing toward the recent Iodine acquisition, the investment firm highlighted Waystar’s expanding AI capabilities and strengthening end-to-end platform for healthcare organizations.
Meanwhile, investor sentiment toward Waystar Holding Corp. (NASDAQ:WAY) appears cautiously optimistic as of the end of January.
On January 28, 2026, Waystar Holding Corp. (NASDAQ:WAY) reached its 52-week low of $28.08, after facing significant pressure. Over the past year, the stock has declined 30.68%, reflecting a gap between market valuation and the potential upside from technology-led expansion and customer penetration.
Waystar Holding Corp. (NASDAQ: WAY) provides healthcare organizations with cloud-based software to streamline payments, improve reimbursement, and enhance the experience for providers, patients, and payers.
While we acknowledge the potential of WAY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: What Are the Best Stocks to Buy Right Now? and 10 Stocks Under $1 That Will Explode.
Disclosure: None.
